Digestive and Liver Disease最新文献

筛选
英文 中文
The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: Enhancing the prognostic utility on the GLOBE scoring system. 原发性胆汁性胆管炎患者抗gp210抗体和抗中心粒抗体的预后价值:提高GLOBE评分系统的预后效用。
IF 4 3区 医学
Digestive and Liver Disease Pub Date : 2025-01-13 DOI: 10.1016/j.dld.2024.12.024
Dawei Ding, Gui Jia, Lina Cui, Yansheng Liu, Xiufang Wang, Ruiqing Sun, Juan Deng, Guanya Guo, Yulong Shang, Ying Han
{"title":"The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: Enhancing the prognostic utility on the GLOBE scoring system.","authors":"Dawei Ding, Gui Jia, Lina Cui, Yansheng Liu, Xiufang Wang, Ruiqing Sun, Juan Deng, Guanya Guo, Yulong Shang, Ying Han","doi":"10.1016/j.dld.2024.12.024","DOIUrl":"https://doi.org/10.1016/j.dld.2024.12.024","url":null,"abstract":"<p><strong>Background: </strong>Positivity for anti-gp210 and anti-centromeric antibodies (ACA) in patients with primary biliary cholangitis (PBC) have been associated with the progression of liver failure and portal hypertension (PH), respectively. The value of combining risk autoantibody assessments with prognostic scoring systems in improving risk assessment in patients with PBC remains unclear.</p><p><strong>Aims: </strong>To investigate the prognostic significance of various combinations of anti-gp210 and ACA statuses and their enhancing the prognostic utility on the GLOBE scoring system.</p><p><strong>Methods: </strong>Stepwise Cox regression was used to estimate the relationship between anti-gp210 antibodies or ACA and liver transplant (LT)-free survival. The GLOBE scoring system was used to stratify the patients.</p><p><strong>Results: </strong>A total of 1412 patients with confirmed PBC were included in the study. The anti-gp210+ status was a significant risk factor for LT/liver-related death, whereas the ACA+ status was a significant risk factor for variceal bleeding (P = 0.002 and 0.007, respectively). The anti-gp210 + ACA + status was a risk indicator for the entire cohort independent of the GLOBE score (P = 0.001, hazard ratio [HR]: 2.649, 95 % confidence interval [CI]: 1.492-4.703) and liver stiffness measurements (LSM; P = 0.039, HR: 4.969, 95 % CI: 1.088-22.692). A significant difference was observed in the area under the receiver operating characteristic curve between the fitted scoring model (consisting of the GLOBE score, anti-gp210 + ACA+ status, and albumin level) and the GLOBE scoring system alone (P = 0.034). When enrolled patients were classified as high-, medium-, and low-risk by the GLOBE scoring system (1.8 and 0.5), the anti-gp210 + ACA+ status was associated with a 1.6- and 3.3-fold higher 5-year incidence of LT/liver-related death in the high- and medium-risk groups, respectively, in comparison with the anti-gp210 + ACA- cases. The anti-gp210 + ACA+ status was also a risk indicator for the presentation of the hepatic failure phenotype in comparison with the anti-gp210- status (P = 0.007, odds ratio [OR]: 6.419, 95 % CI: 1.645-25.042), and the presentation of PH phenotype in comparison with the anti-ACA- status (OR: 3.473, 95 % CI: 1.328-9.018, P = 0.011).</p><p><strong>Conclusion: </strong>The anti-gp210 + ACA+ status was an independent prognostic marker that could predict a poor prognosis in patients with PBC at diagnosis and may further optimise risk stratification in combination with the GLOBE scoring system.</p>","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142982963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author's Reply: "Association of early antibiotic use with risk of ulcerative colitis". 作者回复:“早期使用抗生素与溃疡性结肠炎风险的关系”。
IF 4 3区 医学
Digestive and Liver Disease Pub Date : 2025-01-11 DOI: 10.1016/j.dld.2024.12.017
Junseok Park, Sungjin Woo, Seong-Joon Koh
{"title":"Author's Reply: \"Association of early antibiotic use with risk of ulcerative colitis\".","authors":"Junseok Park, Sungjin Woo, Seong-Joon Koh","doi":"10.1016/j.dld.2024.12.017","DOIUrl":"https://doi.org/10.1016/j.dld.2024.12.017","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive factors of health related quality of life in children and adolescents with celiac disease: An Italian multicenter study on behalf of the SIGENP. 患有乳糜泻的儿童和青少年健康相关生活质量的预测因素:一项代表SIGENP的意大利多中心研究
IF 4 3区 医学
Digestive and Liver Disease Pub Date : 2025-01-11 DOI: 10.1016/j.dld.2024.12.020
Marco Crocco, Federica Malerba, Angela Calvi, Noemi Zampatti, Francesco Valitutti, Livia Pisciotta, Consuelo Borgarelli, Monica Montuori, Salvatore Oliva, Giulia Catassi, Raffaele Borghini, Chiara Maria Trovato, Francesca Ferretti, Enrico Felici, Barbara Roviglione, Alice Monzani, Chiara Terzi, Federico Caldonazzi, Valentina Bortolotti, Elena Cavalli, Rita Cozzali, Maria Teresa Illiceto, Michele Citrano, Francesco Graziano, Claudio Romano, Francesca Laganà, Renata Auricchio, Jacopo Ferro, Paolo Gandullia, Stefania Proietti, Stefano Bonassi
{"title":"Predictive factors of health related quality of life in children and adolescents with celiac disease: An Italian multicenter study on behalf of the SIGENP.","authors":"Marco Crocco, Federica Malerba, Angela Calvi, Noemi Zampatti, Francesco Valitutti, Livia Pisciotta, Consuelo Borgarelli, Monica Montuori, Salvatore Oliva, Giulia Catassi, Raffaele Borghini, Chiara Maria Trovato, Francesca Ferretti, Enrico Felici, Barbara Roviglione, Alice Monzani, Chiara Terzi, Federico Caldonazzi, Valentina Bortolotti, Elena Cavalli, Rita Cozzali, Maria Teresa Illiceto, Michele Citrano, Francesco Graziano, Claudio Romano, Francesca Laganà, Renata Auricchio, Jacopo Ferro, Paolo Gandullia, Stefania Proietti, Stefano Bonassi","doi":"10.1016/j.dld.2024.12.020","DOIUrl":"https://doi.org/10.1016/j.dld.2024.12.020","url":null,"abstract":"<p><strong>Background: </strong>In pediatric patients, celiac disease (CD) may influence the health-related quality of life (HRQoL).</p><p><strong>Aims: </strong>The study aimed to assess HRQoL and further characterise the clinical factors associated with reduced HRQoL, in a large multicenter pediatric cohort with CD.</p><p><strong>Methods: </strong>The disease-specific questionnaire CD Dutch Questionnaire (CDDUX) and the generic questionnaire Paediatric Quality of Life Inventory (PedsQL) were used to assess the HRQoL. Clinical and sociodemographic characteristics were analyzed, univariate and multivariate analysis were conducted.</p><p><strong>Results: </strong>Eleven different Italian pediatric centers and 871 families were involved. Mean age at interview was 12.9 ± 2.9 years. The mean total CDDUX score of CD patients was 47.1 ± 18.8, revealing a neutral HRQoL (47.1 ± 18.8), and a good to very good HRQoL according to the PedsQL (81.4 ± 12.6), parents indicated lower scores (p = 0.03) with both questionnaires (CDDUX 45.1 ± 18.6 and PedsQL 79.9 ± 14.5). Patients with lower HRQoL were mainly female, living in Northern Italy, with lower parent's education level and non-biopsy diagnosis of CD. In multivariate analysis, the main predictor of lower CDDUX score was non-biopsy diagnosis.</p><p><strong>Conclusions: </strong>The HRQoL in a large cohort of Italian children is reported as neutral-good. This indicates a high level of adaptive behaviors in response to the daily challenges of CD. Parents tend to underestimate their children's HRQoL. Specific clinical factors, including non-biopsy diagnosis, may be associated to lower HRQoL.</p>","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-life insights into biliary tract cancers in France from the ACABi GERCOR PRONOBIL cohort. ACABi GERCOR PRONOBIL队列在法国对胆道癌症的真实见解。
IF 4 3区 医学
Digestive and Liver Disease Pub Date : 2025-01-11 DOI: 10.1016/j.dld.2024.12.012
Usama Mehsood, Mohammad Aitzaz Hassan, Muhammad Younas
{"title":"Real-life insights into biliary tract cancers in France from the ACABi GERCOR PRONOBIL cohort.","authors":"Usama Mehsood, Mohammad Aitzaz Hassan, Muhammad Younas","doi":"10.1016/j.dld.2024.12.012","DOIUrl":"https://doi.org/10.1016/j.dld.2024.12.012","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing bias and inconsistencies in antiTNF-induced psoriasis management. 解决抗tnf诱导的牛皮癣管理中的偏见和不一致。
IF 4 3区 医学
Digestive and Liver Disease Pub Date : 2025-01-11 DOI: 10.1016/j.dld.2024.12.015
Saad Khan, Ayesha Khan, Faraz Arshad, Fatima Naveed, Rizwan Ahmad
{"title":"Addressing bias and inconsistencies in antiTNF-induced psoriasis management.","authors":"Saad Khan, Ayesha Khan, Faraz Arshad, Fatima Naveed, Rizwan Ahmad","doi":"10.1016/j.dld.2024.12.015","DOIUrl":"https://doi.org/10.1016/j.dld.2024.12.015","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Change in fatigue in patients with ulcerative colitis or Crohn's disease initiating biologic therapy. 溃疡性结肠炎或克罗恩病患者开始生物治疗后的疲劳变化
IF 4 3区 医学
Digestive and Liver Disease Pub Date : 2025-01-08 DOI: 10.1016/j.dld.2024.12.011
Edouard Louis, Peter Bossuyt, Arnaud Colard, Antoine Nakad, Didier Baert, Fazia Mana, Philip Caenepeel, Stijn Vanden Branden, Severine Vermeire, Francois D'Heygere, Beatrijs Strubbe, Anneline Cremer, Vida Setakhr, Filip Baert, Anne Vijverman, Jean-Louis Coenegrachts, Frederic Flamme, Anke Hantson, Jie Zhou, Geert Van Gassen
{"title":"Change in fatigue in patients with ulcerative colitis or Crohn's disease initiating biologic therapy.","authors":"Edouard Louis, Peter Bossuyt, Arnaud Colard, Antoine Nakad, Didier Baert, Fazia Mana, Philip Caenepeel, Stijn Vanden Branden, Severine Vermeire, Francois D'Heygere, Beatrijs Strubbe, Anneline Cremer, Vida Setakhr, Filip Baert, Anne Vijverman, Jean-Louis Coenegrachts, Frederic Flamme, Anke Hantson, Jie Zhou, Geert Van Gassen","doi":"10.1016/j.dld.2024.12.011","DOIUrl":"https://doi.org/10.1016/j.dld.2024.12.011","url":null,"abstract":"<p><strong>Background: </strong>Fatigue is common among patients with inflammatory bowel diseases (IBDs) and is associated with decreased quality of life (QoL).</p><p><strong>Aims: </strong>Describe fatigue evolution and identify factors associated with fatigue outcomes in patients with ulcerative colitis (UC) or Crohn's disease (CD) initiating biologic treatment.</p><p><strong>Methods: </strong>Data from adult Belgian patients with UC or CD enrolled in a prospective real-world study were utilized. Fatigue and QoL were assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) and the Short Inflammatory Bowel Disease Questionnaire, respectively. Factors associated with fatigue outcomes were assessed using multivariate regression.</p><p><strong>Results: </strong>465 patients were included: 174 with UC and 291 with CD. Average FACIT-F scores indicated improvements in fatigue after 6 months, before stabilizing. A higher probability of fatigue disappearance was associated with clinical remission and was more likely in patients with UC than CD. Patients achieving clinical remission had lower probability of fatigue. Patients with fatigue improvements experienced greater QoL improvements than patients with fatigue persistence.</p><p><strong>Conclusions: </strong>Real-world findings suggest fatigue partly improves in the first 6 months of biologic treatment. Clinical remission was associated with greater probability of fatigue disappearance and lower likelihood of fatigue persistence. Further research into factors associated with fatigue in patients with IBD is warranted.</p>","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142946419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: "Measured glomerular filtration rate based on iohexol: Towards an application in liver transplantation." 评论:“基于碘己醇的肾小球滤过率测定:在肝移植中的应用”。
IF 4 3区 医学
Digestive and Liver Disease Pub Date : 2025-01-07 DOI: 10.1016/j.dld.2024.12.013
Paul Carrier, Jean-Baptiste Woillard, Marilyne Debette-Gratien, Véronique Loustaud-Ratti
{"title":"Comment on: \"Measured glomerular filtration rate based on iohexol: Towards an application in liver transplantation.\"","authors":"Paul Carrier, Jean-Baptiste Woillard, Marilyne Debette-Gratien, Véronique Loustaud-Ratti","doi":"10.1016/j.dld.2024.12.013","DOIUrl":"https://doi.org/10.1016/j.dld.2024.12.013","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142946425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammatory bowel disease, MASLD, and cardiometabolic risks: Unveiling a new perspective on mortality risk. 炎症性肠病、MASLD和心脏代谢风险:揭示死亡风险的新视角
IF 4 3区 医学
Digestive and Liver Disease Pub Date : 2025-01-04 DOI: 10.1016/j.dld.2024.12.016
FaYuan Wang, Guilin Nie, Ping He
{"title":"Inflammatory bowel disease, MASLD, and cardiometabolic risks: Unveiling a new perspective on mortality risk.","authors":"FaYuan Wang, Guilin Nie, Ping He","doi":"10.1016/j.dld.2024.12.016","DOIUrl":"https://doi.org/10.1016/j.dld.2024.12.016","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142930883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Paediatric-onset autoimmune liver disease: Insights from a monocentric experience". 对“儿科发病的自身免疫性肝病:来自单一中心经验的见解”的评论。
IF 4 3区 医学
Digestive and Liver Disease Pub Date : 2025-01-04 DOI: 10.1016/j.dld.2024.12.008
Qateen Zahra, Javeria Zulfiqar Cheema, Muhammad Rafay Shahzad Cheema
{"title":"Comment on \"Paediatric-onset autoimmune liver disease: Insights from a monocentric experience\".","authors":"Qateen Zahra, Javeria Zulfiqar Cheema, Muhammad Rafay Shahzad Cheema","doi":"10.1016/j.dld.2024.12.008","DOIUrl":"https://doi.org/10.1016/j.dld.2024.12.008","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142930882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in incidence of infrequent and frequent synchronous metastases from colorectal cancer 结直肠癌不常见和常见同步转移的发病率趋势。
IF 4 3区 医学
Digestive and Liver Disease Pub Date : 2025-01-01 DOI: 10.1016/j.dld.2024.06.018
Valérie Jooste , Côme Lepage , Sylvain Manfredi , Anne-Marie Bouvier
{"title":"Trends in incidence of infrequent and frequent synchronous metastases from colorectal cancer","authors":"Valérie Jooste ,&nbsp;Côme Lepage ,&nbsp;Sylvain Manfredi ,&nbsp;Anne-Marie Bouvier","doi":"10.1016/j.dld.2024.06.018","DOIUrl":"10.1016/j.dld.2024.06.018","url":null,"abstract":"<div><h3>Background</h3><div>Population-based data on the incidence of frequent colorectal metastases are fairly scarce, while that on rare metastatic sites are lacking.</div></div><div><h3>Aims</h3><div>The aim of this study was to provide epidemiological indicators of metastatic sites frequency in patients with colorectal cancer.</div></div><div><h3>Methods</h3><div>Incidence was modelled using Poisson and Joinpoint regressions in a population-based cancer registry study including metastatic colorectal cancers diagnosed between 1991 and 2020 (<em>N</em> = 5,199). Tumor molecular markers were collected for the [2016–2020] period.</div></div><div><h3>Results</h3><div>Liver, peritoneum, lung and bone were the most frequent metastatic sites. Among frequent sites, incidence of liver and lung sites decreased in men respectively since 1999 and 2010, whereas in women incidence of liver and peritoneum sites increased steadily throughout the whole period. Each of the other sites concerned less than 3% of metastatic colorectal cancer cases and presented standardized incidence rates between 0.19 and 1.39 per 1,000,000. Among rare sites, incidence of adrenal glands, supraclavicular lymph node, mediastinum and ascites had doubled in [2016–2020] as compared to the 25 previous years. BRAFV600E variant was more frequent in presence of carcinomatosis, and absence of liver and lung metastasis while KRAS variant was more frequent in presence of lung metastasis.</div></div><div><h3>Conclusion</h3><div>This study provides unprecedented incidence indicators for rare synchronous metastases of colorectal cancer.</div></div>","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":"57 1","pages":"Pages 83-88"},"PeriodicalIF":4.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141554402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信